J1413 – Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ1413
- Long description
- Injection, delandistrogene moxeparvovec-rokl, per therapeutic dose
- Short description
- Inj delandistrogene mox rokl
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- ASC
- Approved for ambulatory surgical centers
- Added
- January 1, 2024
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J1413?
J1413 is a HCPCS Level II code for injection, delandistrogene moxeparvovec-rokl, per therapeutic dose.
Does Medicare cover J1413?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J1330 – Injection, ergonovine maleate, up to 0.2 mg
- J1335 – Injection, ertapenem sodium, 500 mg
- J1364 – Injection, erythromycin lactobionate, per 500 mg
- J1370 – Injection, esomeprazole sodium, 1 mg
- J1380 – Injection, estradiol valerate, up to 10 mg
- J1410 – Injection, estrogen conjugated, per 25 mg
- J1411 – Injection, etranacogene dezaparvovec-drlb, per therapeutic dose
- J1412 – Injection, valoctocogene roxaparvovec-rvox, per ml, containing nominal 2 x 10^13 vector genomes
- J1414 – Injection, fidanacogene elaparvovec-dzkt, per therapeutic dose
- J1426 – Injection, casimersen, 10 mg
- J1427 – Injection, viltolarsen, 10 mg
- J1428 – Injection, eteplirsen, 10 mg
- J1429 – Injection, golodirsen, 10 mg
- J1430 – Injection, ethanolamine oleate, 100 mg
- J1434 – Injection, fosaprepitant (focinvez), 1 mg
- J1435 – Injection, estrone, per 1 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.